← Back to Search

MED-Go App for Sickle Cell Disease

N/A
Recruiting
Led By Sherif M. Badawy, MD, MS
Research Sponsored by Ann & Robert H Lurie Children's Hospital of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 12-21 years old
On steady state of hydroxyurea for 2 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial will test a new app to help people with sickle cell disease take their medication as prescribed. The goal is to improve health outcomes for these patients.

Who is the study for?
This trial is for adolescents and young adults aged 12-21 with any type of sickle cell disease who have been on hydroxyurea steadily for at least 2 months. Participants must own or have access to a smartphone. Those recently hospitalized within the past week cannot join.Check my eligibility
What is being tested?
The MED-Go app, a behavioral intervention designed to help young people with sickle cell disease take their medication regularly, is being tested for its ease of use and whether it's well-received by users in this pilot randomized controlled trial.See study design
What are the potential side effects?
Since the intervention involves using an app (MED-Go) aimed at improving medication adherence, there are no direct medical side effects associated with it. However, participants may experience issues related to technology use such as eye strain or stress.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 12 and 21 years old.
Select...
I have been taking hydroxyurea consistently for 2 months.
Select...
I have a type of sickle cell disease.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of patients achieving feasibility criteria of using the MED-Go app
Secondary outcome measures
Hydroxyurea adherence rates
Scores of System Usability Scale (SUS)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MED-Go app InterventionExperimental Treatment1 Intervention
Participants will use MED-Go app intervention for a total of 12 weeks
Group II: Control ArmActive Control1 Intervention
Standard of care

Find a Location

Who is running the clinical trial?

Ann & Robert H Lurie Children's Hospital of ChicagoLead Sponsor
253 Previous Clinical Trials
5,187,688 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,819 Previous Clinical Trials
47,295,717 Total Patients Enrolled
Sherif M. Badawy, MD, MSPrincipal InvestigatorAnn & Robert H Lurie Children's Hospital of Chicago
2 Previous Clinical Trials
101 Total Patients Enrolled

Media Library

MED-Go App Clinical Trial Eligibility Overview. Trial Name: NCT04688411 — N/A
Sickle Cell Disease Research Study Groups: Control Arm, MED-Go app Intervention
Sickle Cell Disease Clinical Trial 2023: MED-Go App Highlights & Side Effects. Trial Name: NCT04688411 — N/A
MED-Go App 2023 Treatment Timeline for Medical Study. Trial Name: NCT04688411 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria makes a person qualified to take part in this clinical trial?

"For this investigation, 40 children aged 12 to 21 with anemia and sickle cell must be recruited. In addition, all participants should possess or have access to a smartphone over the period of the trial."

Answered by AI

Is the age range for participation in this experiment extending beyond 30 years?

"Adhering to the trial's regulations, individuals aged 12-21 may be enrolled as participants."

Answered by AI

Are there currently opportunities for participants in this experiment?

"As per clinicaltrials.gov records, this medical research is still in the process of recruiting volunteers. The trial was initiated on September 28th 2020 with recent modifications made to it on March 7th 2022."

Answered by AI

What is the upper limit of enrollees for this clinical trial?

"Affirmative. According to clinicaltrials.gov, this experiment began recruiting on September 28th 2020 and recently amended its information on March 7th 2022. This trial requires 40 individuals from a single medical facility for participation."

Answered by AI
~9 spots leftby Mar 2025